Literature DB >> 8501912

Prognostic factors for well-differentiated squamous cell carcinoma in the oral cavity with emphasis on immunohistochemical evaluation.

K Horiuchi1, K Mishima, M Ohsawa, M Sugimura, K Aozasa.   

Abstract

Histological and immunohistological prognostic factors for well-differentiated oral squamous cell carcinoma (SCC) were examined in 31 patients. They included 18 males and 13 females aged 42-84 (median 63) years. The tumors were located in the tongue in 13 cases, gingiva in 7, floor of the mouth in 5, cheek mucosa in 4, and palate in 2. Advanced disease (stages III and IV) was found in 92% of patients; 22 were treated by radical surgery and nine by excisional or incisional biopsy, followed by adjuvant chemotherapy and external radiation. The 5-year survival rate in patients with stages III and IV disease was 58% and 33%, respectively. Histologic factors evaluated were tumor cell mitotic counts, degree of lymphocyte and eosinophil infiltration around the tumor, mast cell counts, HLA-DR expression on tumor cells, or surrounding lymphocytes. Multivariate analysis revealed that degree of eosinophilic infiltration and expression of HLA-DR antigen on the tumor cells were significant factors for prognosis (P < 0.05); i.e., heavy eosinophilic infiltration and expression of HLA-DR antigen on tumor cells were signs of an unfavorable prognosis. The interpretation of the present findings are discussed with a review of the literature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501912     DOI: 10.1002/jso.2930530209

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  25 in total

1.  Eosinophils may predict occult lymph node metastasis in early oral cancer.

Authors:  D T Oliveira; T P Biassi; S E S Faustino; A L Carvalho; G Landman; L P Kowalski
Journal:  Clin Oral Investig       Date:  2011-12-14       Impact factor: 3.573

2.  Tumour-Associated Tissue Eosinophilia in Oral Squamous Cell Carcinoma- A Boon or a Bane?

Authors:  Shweta Yellapurkar; Srikant Natarajan; Karen Boaz; Mohan Baliga; Premalatha Shetty; Nidhi Manaktala; Mukul Prasad; Mahalakshmi Ravi
Journal:  J Clin Diagn Res       Date:  2016-04-01

3.  Quantitative Evaluation of Tumour--Associated Tissue Eosinophilia and Cyclo-oxegenase-2 Gene in Oral Cancer Patients with Assessment of Long Term Outcomes.

Authors:  N Rakesh; Asha Iyengar; Kuhu Majumdar; G S Vidya; S S Shantha Kumar
Journal:  Pathol Oncol Res       Date:  2015-11-17       Impact factor: 3.201

Review 4.  Myeloid Cells as Targets for Therapy in Solid Tumors.

Authors:  Tiziana Cotechini; Terry R Medler; Lisa M Coussens
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

5.  CCL24 Signaling in the Tumor Microenvironment.

Authors:  Sung-Jig Lim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils.

Authors:  Bing Zhang; Chun-Yan Wei; Kai-Kai Chang; Jia-Jun Yu; Wen-Jie Zhou; Hui-Li Yang; Jun Shao; Jin-Jin Yu; Ming-Qing Li; Feng Xie
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

Review 7.  Tumor associated tissue eosinophilia in oral squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Nilookumari Choudhary; Gargi S Sarode; Monal Yuwanati; Nikunj Maniyar; Sachin C Sarode; Amol R Gadbail; Shailesh Gondivkar; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2020-11-23

8.  Eosinophils and oral squamous cell carcinoma: a short review.

Authors:  C P Martinelli-Kläy; B R R N Mendis; T Lombardi
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

9.  Eosinophils in human oral squamous carcinoma; role of prostaglandin D2.

Authors:  Francis Davoine; Adrian Sim; Charlie Tang; Sibina Fisher; Caroline Ethier; Lakshmi Puttagunta; Yingqi Wu; W Tim McGaw; Donald Yu; Lisa Cameron; Darryl J Adamko; Redwan Moqbel
Journal:  J Inflamm (Lond)       Date:  2013-01-31       Impact factor: 4.981

10.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.